Abstract:Dendritic cells (DC) are currently recognized as the most effective professional antigen-presenting cells in the world. They regulate the differentiation of initial CD4+Th cells through recognition, uptake and presentation of antigenic antigen, affect the Th1/Th2 balance, and play an important role in the immune regulatory response of allergic rhinitis. Studies have shown that tolerogenic dendritic cells (tDC) can not only effectively inhibit effector T cells to cause immune tolerance, but also induce the activation of regulatory T cells to produce immune tolerance, so as to reduce the inflammatory response of the upper respiratory tract, which makes tDC as a possible choice in the clinical immune prevention and treatment of allergic rhinitis. It will provide new theoretical support for the application of tDC in the clinical prevention and treatment of allergic rhinitis that to explain the relationship between tDC and immune cells, master the basic biological characteristics of tDC, the necessary conditions for its formation, and the interaction with inflammatory cells. This paper will systematically analyze and summarize the phenotypic and biological characteristics of tDC, the mechanism and application prospect of regulating Th1/Th2 balance and inducing immune tolerance, and review the relevant experimental research in recent years.